RESEARCHReferences1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L,Magassouba N, et al. Emergence of Zaire Ebola virus disease inGuinea—preliminary report. N Engl J Med. 2014;371:1418–25.http://dx.doi.org/10.1056/NEJMoa14045052. Hawkes N. Ebola outbreak is a public health emergency ofinternational concern, WHO warns. BMJ. 2014;349:g5089.http://dx.doi.org/10.1136/bmj.g50893. Yozwiak NL, Schaffner SF, Sabeti PC. Data sharing: makeoutbreak research open access. Nature. 2015;518:477–9.http://dx.doi.org/10.1038/518477a4. World Health Organization. Ebola situation report—11 March 2015[cited 2015 Mar 30]. http://apps.who.int/ebola/current-situation/ebola-situation-report-11-march-20155. Chan M. WHO report by the Director-General to the specialsession of the Executive Board on Ebola [cited 2015 Mar 30].http://www.who.int/dg/speeches/2015/executive-board-ebola/en/6. Kugelman JR, Sanchez-Lockhart M, Andersen KG, Gire S,Park DJ, Sealfon R, et al. Evaluation of the potential impact ofEbola virus genomic drift on the efficacy of sequence-basedcandidate therapeutics. MBio. 2015;6:e02227-14. http://dx.doi.org/10.1128/mBio.02227-147. Shuchman M. WHO enters new terrain in Ebola research. CMAJ.2014;186:E527–8. http://dx.doi.org/10.1503/cmaj.109-48938. Sayburn A. WHO gives go ahead for experimental treatments to beused in Ebola outbreak. BMJ. 2014;349:g5161. http://dx.doi.org/10.1136/bmj.g51619. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA,Jahrling J, Hensley LE, et al. Comprehensive panel of real-timeTaqMan polymerase chain reaction assays for detection andabsolute quantification of filoviruses, arenaviruses, andNew World hantaviruses. Am J Trop Med Hyg. 2010;82:954–60.http://dx.doi.org/10.4269/ajtmh.2010.09-063610. Kuhn JH, Andersen KG, Baize S, Bao Y, Bavari S, Berthet N, et al.Nomenclature- and database-compatible names for the two Ebolavirus variants that emerged in Guinea and the DemocraticRepublic of the Congo in 2014. Viruses. 2014;6:4760–99.http://dx.doi.org/10.3390/v611476011. Djikeng A, Halpin R, Kuzmickas R, Depasse J, Feldblyum J,Sengamalay N, et al. Viral genome sequencing by randompriming methods. BMC Genomics. 2008;9:5. http://dx.doi.org/10.1186/1471-2164-9-512. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L,et al. Genomic surveillance elucidates Ebola virus origin andtransmission during the 2014 outbreak. Science. 2014;345:1369–72. http://dx.doi.org/10.1126/science.125965713. Martin M. Cutadapt removes adapter sequences from highthroughputsequencing reads. EMBnetjournal. 2011;17:10–2.14. Schmieder R, Edwards R. Quality control and preprocessingof metagenomic datasets. Bioinformatics. 2011;27:863–4.http://dx.doi.org/10.1093/bioinformatics/btr02615. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al.The sequence alignment/map format and SAMtools. Bioinformatics.2009;25:2078–9. http://dx.doi.org/10.1093/bioinformatics/btp35216. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L,et al. A program for annotating and predicting the effects ofsingle nucleotide polymorphisms, SnpEff: SNPs in the genome ofDrosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin).2012;6:80–92. http://dx.doi.org/10.4161/fly.1969517. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesianphylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol.2012;29:1969–73. http://dx.doi.org/10.1093/molbev/mss07518. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W,Gascuel O. New algorithms and methods to estimate maximum-likelihoodphylogenies: assessing the performance of PhyML 3.0. SystBiol. 2010;59:307–21. http://dx.doi.org/10.1093/sysbio/syq01019. Ladner JT, Beitzel B, Chain PS, Davenport MG, Donaldson EF,Frieman M, et al. Standards for sequencing viral genomes in theera of high-throughput sequencing. MBio. 2014;5:e01360-14.http://dx.doi.org/10.1128/mBio.01360-1420. Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN,Sood V, et al. Postexposure protection of non-human primatesagainst a lethal Ebola virus challenge with RNA interference:a proof-of-concept study. Lancet. 2010;375:1896–905.http://dx.doi.org/10.1016/S0140-6736(10)60357-121. Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS,Van Tongeren SA, et al. Advanced antisense therapies for postexposureprotection against lethal filovirus infections. Nat Med.2010;16:991–4. http://dx.doi.org/10.1038/nm.220222. Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, et al.Sustained protection against Ebola virus infection followingtreatment of infected nonhuman primates with ZMAb. Sci Rep.2013;3:3365. http://dx.doi.org/10.1038/srep0336523. Pettitt J, Zeitlin L, Kim DH, Working C, Johnson JC, Bohorov O,et al. Therapeutic intervention of Ebola virus infection in rhesusmacaques with the MB-003 monoclonal antibody cocktail.Sci Transl Med. 2013;5:199ra113.24. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al.Re<strong>version</strong> of advanced Ebola virus disease in nonhuman primateswith ZMapp. Nature. 2014;514:47–53.25. Olinger GG Jr, Pettitt J, Kim D, Working C, Bohorov O,Bratcher B, et al. Delayed treatment of Ebola virus infection withplant-derived monoclonal antibodies provides protection in rhesusmacaques. Proc Natl Acad Sci U S A. 2012;109:18030–5.http://dx.doi.org/10.1073/pnas.121370910926. Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA,Zak SE, et al. Postexposure antibody prophylaxis protectsnonhuman primates from filovirus disease. Proc Natl AcadSci U S A. 2012;109:5034–9. http://dx.doi.org/10.1073/pnas.120040910927. Heald AE, Iversen PL, Saoud JB, Sazani P, Charleston JS,Axtelle T, et al. Safety and pharmacokinetic profiles ofphosphorodiamidate morpholino oligomers with activity againstEbola virus and Marburg virus: results of two single-ascendingdosestudies. Antimicrob Agents Chemother. 2014;58:6639–47.http://dx.doi.org/10.1128/AAC.03442-1428. Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, et al.Virus nomenclature below the species level: a standardizednomenclature for natural variants of viruses assigned to thefamily Filoviridae. Arch Virol. 2013;158:301–11. http://dx.doi.org/10.1007/s00705-012-1454-029. Rezler JP. Tekmira provides periodic update on TKM-Ebolaprogram [cited 2015 Mar 30]. http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=87739730. Wilson JA, Hevey M, Bakken R, Guest S, Bray M,Schmaljohn AL, et al. Epitopes involved in antibody-mediatedprotection from Ebola virus. Science. 2000;287:1664–6.http://dx.doi.org/10.1126/science.287.5458.166431. Qiu X, Alimonti JB, Melito PL, Fernando L, Stroher U, Jones SM.Characterization of Zaire ebolavirus glycoprotein-specificmonoclonal antibodies. Clin Immunol. 2011;141:218–27.http://dx.doi.org/10.1016/j.clim.2011.08.00832. Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS,Huggins JW, et al. Generation of eGFP expressing recombinantZaire ebolavirus for analysis of early pathogenesis events andhigh-throughput antiviral drug screening. Virology. 2005;332:20–7.http://dx.doi.org/10.1016/j.virol.2004.10.04833. Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN,Ruthel G, et al. Chemical modifications of antisense morpholinooligomers enhance their efficacy against Ebola virus infection.Antimicrob Agents Chemother. 2009;53:2089–99.http://dx.doi.org/10.1128/AAC.00936-081142 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015
Monitoring Ebola Virus Makona Evolution34. Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB,Daddario-DiCaprio K, et al. Postexposure protection of guineapigs against a lethal Ebola virus challenge is conferred by RNAinterference. J Infect Dis. 2006;193:1650–7. http://dx.doi.org/10.1086/50426735. Theriault S, Groseth A, Neumann G, Kawaoka Y, Feldmann H.Rescue of Ebola virus from cDNA using heterologous supportproteins. Virus Res. 2004;106:43–50. http://dx.doi.org/10.1016/j.virusres.2004.06.00236. Martínez MJ, Biedenkopf N, Volchkova V, Hartlieb B,Alazard-Dany N, Reynard O, et al. Role of Ebola virus VP30 intranscription reinitiation. J Virol. 2008;82:12569–73.http://dx.doi.org/10.1128/JVI.01395-0837. Biedenkopf N, Hartlieb B, Hoenen T, Becker S. Phosphorylation ofEbola virus VP30 influences the composition of the viralnucleocapsid complex: impact on viral transcription and replication.J Biol Chem. 2013;288:11165–74. http://dx.doi.org/10.1074/jbc.M113.46128538. Carroll SA, Towner JS, Sealy TK, McMullan LK, Khristova ML,Burt FJ, et al. Molecular evolution of viruses of the familyFiloviridae based on 97 whole-genome sequences. J Virol.2013;87:2608–16. http://dx.doi.org/10.1128/JVI.03118-1239. World Health Organization. Mali: details of the additional casesof Ebola virus disease [cited 2015 Mar 30]. http://www.who.int/mediacentre/news/ebola/20-november-2014-mali/en/Address for correspondence: Gustavo Palacios, Center for GenomeSciences, USAMRIID, 1425 Porter St, Fort Detrick, Frederick, MD21702, USA; email: gustavo.f.palacios.ctr@us.army.milEmerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015 1143
- Page 3 and 4: July 2015SynopsisOn the CoverMarian
- Page 5 and 6: 1240 Gastroenteritis OutbreaksCause
- Page 7 and 8: SYNOPSISDisseminated Infections wit
- Page 9 and 10: Disseminated Infections with Talaro
- Page 11 and 12: Disseminated Infections with Talaro
- Page 13 and 14: Macacine Herpesvirus 1 inLong-Taile
- Page 15 and 16: Macacine Herpesvirus 1 in Macaques,
- Page 17 and 18: Macacine Herpesvirus 1 in Macaques,
- Page 19: Macacine Herpesvirus 1 in Macaques,
- Page 23: Malaria among Young Infants, Africa
- Page 26 and 27: RESEARCHFigure 3. Dynamics of 19-kD
- Page 28 and 29: Transdermal Diagnosis of MalariaUsi
- Page 30 and 31: RESEARCHFigure 2. A) Acoustic trace
- Page 32 and 33: RESEARCHof malaria-infected mosquit
- Page 34 and 35: Lack of Transmission amongClose Con
- Page 36 and 37: RESEARCH(IFA) and microneutralizati
- Page 38 and 39: RESEARCHoropharyngeal, and serum sa
- Page 40 and 41: RESEARCH6. Assiri A, McGeer A, Perl
- Page 42 and 43: RESEARCHadvanced genomic sequencing
- Page 44 and 45: RESEARCHTable 2. Next-generation se
- Page 46 and 47: RESEARCHTable 3. Mutation analysis
- Page 50 and 51: Parechovirus Genotype 3 Outbreakamo
- Page 52 and 53: RESEARCHFigure 1. Venn diagramshowi
- Page 54 and 55: RESEARCHTable 2. HPeV testing of sp
- Page 56 and 57: RESEARCHFigure 5. Distribution of h
- Page 58 and 59: RESEARCHReferences1. Selvarangan R,
- Page 60 and 61: RESEARCHthe left lobe was sampled b
- Page 62 and 63: RESEARCHTable 2. Middle East respir
- Page 64 and 65: RESEARCHseroprevalence in domestic
- Page 66 and 67: RESEARCHmeasure their current surve
- Page 68 and 69: RESEARCHTable 2. States with labora
- Page 70 and 71: RESEARCHFigure 2. Comparison of sur
- Page 72 and 73: RESEARCH9. Centers for Disease Cont
- Page 74 and 75: RESEARCHthe analyses. Cases in pers
- Page 76 and 77: RESEARCHTable 3. Sampling results (
- Page 78 and 79: RESEARCHpresence of Legionella spp.
- Page 80 and 81: Seroprevalence for Hepatitis Eand O
- Page 82 and 83: RESEARCHTable 1. Description of stu
- Page 84 and 85: RESEARCHTable 3. Crude and adjusted
- Page 86 and 87: RESEARCHrates by gender or HIV stat
- Page 88 and 89: RESEARCH25. Taha TE, Kumwenda N, Ka
- Page 90 and 91: POLICY REVIEWDutch Consensus Guidel
- Page 92 and 93: POLICY REVIEWTable 3. Comparison of
- Page 94 and 95: POLICY REVIEW6. Botelho-Nevers E, F
- Page 96 and 97: DISPATCHESFigure 1. Phylogenetic tr
- Page 98 and 99:
DISPATCHESSevere Pediatric Adenovir
- Page 100 and 101:
DISPATCHESTable 1. Demographics and
- Page 102 and 103:
DISPATCHES13. Kim YJ, Hong JY, Lee
- Page 104 and 105:
DISPATCHESTable. Alignment of resid
- Page 106 and 107:
DISPATCHESFigure 2. Interaction of
- Page 108 and 109:
DISPATCHESSchmallenberg Virus Recur
- Page 110 and 111:
DISPATCHESFigure 2. Detection of Sc
- Page 112 and 113:
DISPATCHESFigure 1. Histopathologic
- Page 114:
DISPATCHESFigure 2. Detection of fo
- Page 117 and 118:
Influenza Virus Strains in the Amer
- Page 119 and 120:
Novel Arenavirus Isolates from Nama
- Page 121 and 122:
Novel Arenaviruses, Southern Africa
- Page 123 and 124:
Readability of Ebola Informationon
- Page 125 and 126:
Readability of Ebola Information on
- Page 127 and 128:
Patients under investigation for ME
- Page 129 and 130:
Patients under investigation for ME
- Page 131 and 132:
Wildlife Reservoir for Hepatitis E
- Page 133 and 134:
Asymptomatic Malaria and Other Infe
- Page 135 and 136:
Asymptomatic Malaria in Children fr
- Page 137 and 138:
Bufavirus in Wild Shrews and Nonhum
- Page 139 and 140:
Bufavirus in Wild Shrews and Nonhum
- Page 141 and 142:
Range Expansion for Rat Lungworm in
- Page 143 and 144:
Slow Clearance of Plasmodium falcip
- Page 145 and 146:
Slow Clearance of Plasmodium falcip
- Page 147 and 148:
Gastroenteritis Caused by Norovirus
- Page 149 and 150:
Ebola Virus Stability on Surfaces a
- Page 151 and 152:
Ebola Virus Stability on Surfaces a
- Page 153 and 154:
Outbreak of Ciprofloxacin-Resistant
- Page 155 and 156:
Outbreak of S. sonnei, South KoreaT
- Page 157 and 158:
Rapidly Expanding Range of Highly P
- Page 159 and 160:
Cluster of Ebola Virus Disease, Bon
- Page 161 and 162:
Cluster of Ebola Virus Disease, Lib
- Page 163 and 164:
ANOTHER DIMENSIONThe Past Is Never
- Page 165 and 166:
Measles Epidemic, Boston, Massachus
- Page 167 and 168:
LETTERSInfluenza A(H5N6)Virus Reass
- Page 169 and 170:
LETTERSsystem (8 kb-span paired-end
- Page 171 and 172:
LETTERS3. Van Hong N, Amambua-Ngwa
- Page 173 and 174:
LETTERSTable. Prevalence of Bartone
- Page 175 and 176:
LETTERSavian influenza A(H5N1) viru
- Page 177 and 178:
LETTERSprovinces and a total of 200
- Page 179 and 180:
LETTERS7. Manian FA. Bloodstream in
- Page 181 and 182:
LETTERSforward projections. N Engl
- Page 183 and 184:
LETTERS3. Guindon S, Gascuel OA. Si
- Page 185 and 186:
BOOKS AND MEDIAin the port cities o
- Page 187 and 188:
ABOUT THE COVERNorth was not intere
- Page 189 and 190:
Earning CME CreditTo obtain credit,
- Page 191:
Emerging Infectious Diseases is a p
Change language